Följ
Marko Anderluh
Marko Anderluh
Full Prof. of Medicinal Chemistry, University of Ljubljana, Faculty of Pharmacy
Verifierad e-postadress på guest.arnes.si - Startsida
Titel
Citeras av
Citeras av
År
C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity
U Švajger, M Anderluh, M Jeras, N Obermajer
Cellular signalling 22 (10), 1397-1405, 2010
3232010
Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site
T Tomasic, S Katsamakas, Z Hodnik, J Ilaš, M Brvar, T Solmajer, ...
Journal of medicinal chemistry 58 (14), 5501-5521, 2015
1362015
Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted …
A Šmelcerović, K Tomović, Ž Šmelcerović, Ž Petronijević, G Kocić, ...
European journal of medicinal chemistry 135, 491-516, 2017
1262017
5‐Benzylidenethiazolidin‐4‐ones as multitarget inhibitors of bacterial Mur ligases
T Tomašić, N Zidar, A Kovač, S Turk, M Simčič, D Blanot, ...
ChemMedChem: Chemistry Enabling Drug Discovery 5 (2), 286-295, 2010
942010
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions
NH Shirole, D Pal, ER Kastenhuber, S Senturk, J Boroda, P Pisterzi, ...
elife 5, e17929, 2016
832016
Synthesis of Novel DC‐SIGN Ligands with an α‐Fucosylamide Anchor
G Timpano, G Tabarani, M Anderluh, D Invernizzi, F Vasile, D Potenza, ...
ChemBioChem 9 (12), 1921-1930, 2008
812008
Toward a Novel Class of Antithrombotic Compounds with Dual Function. Discovery of 1,4-Benzoxazin-3(4H)-one Derivatives Possessing Thrombin Inhibitory and …
P Štefanič Anderluh, M Anderluh, J Ilaš, J Mravljak, M Sollner Dolenc, ...
Journal of medicinal chemistry 48 (9), 3110-3113, 2005
812005
Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
K Tomovic, J Lazarevic, G Kocic, M Deljanin‐Ilic, M Anderluh, ...
Medicinal research reviews 39 (1), 404-422, 2019
802019
Three-component one-pot synthetic route to 2-amino-5-alkylidene-thiazol-4-ones
M Anderluh, M Jukič
Tetrahedron 65 (1), 344-350, 2009
652009
Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: potential impact of dipeptidyl peptidase-4 inhibitors
M Anderluh, G Kocic, K Tomovic, R Kocic, M Deljanin-Ilic, A Smelcerovic
Pharmacology & therapeutics 167, 100-107, 2016
622016
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs) Miniperspective
A Kolarič, M Anderluh, N Minovski
Journal of medicinal chemistry 63 (11), 5664-5674, 2020
602020
Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists
N Obermajer, S Sattin, C Colombo, M Bruno, U Švajger, M Anderluh, ...
Molecular Diversity 15, 347-360, 2011
592011
Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-ones
Z Smelcerovic, A Veljkovic, G Kocic, D Yancheva, Z Petronijevic, ...
Chemico-biological interactions 229, 73-81, 2015
542015
DC-SIGN antagonists, a potential new class of anti-infectives
M Anderluh, G Jug, U Svajger, N Obermajer
Current medicinal chemistry 19 (7), 992-1007, 2012
542012
Recent advances on smart glycoconjugate vaccines in infections and cancer
M Anderluh, F Berti, A Bzducha‐Wróbel, F Chiodo, C Colombo, ...
The FEBS journal 289 (14), 4251-4303, 2022
502022
Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1, 4-benzoxazine-3 (4H)-one scaffold. A systematic study
M Anderluh, J Cesar, P Štefanič, D Kikelj, D Janeš, J Murn, K Nadrah, ...
European journal of medicinal chemistry 40 (1), 25-49, 2005
482005
Monovalent and bivalent N-fucosyl amides as high affinity ligands for Pseudomonas aeruginosa PA-IIL lectin
M Andreini, M Anderluh, A Audfray, A Bernardi, A Imberty
Carbohydrate research 345 (10), 1400-1407, 2010
462010
New biologically active epidioxysterols from Stereum hirsutum
F Cateni, B Doljak, M Zacchigna, M Anderluh, A Piltaver, G Scialino, ...
Bioorganic & medicinal chemistry letters 17 (22), 6330-6334, 2007
452007
Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds
A Kolarič, T Germe, M Hrast, CEM Stevenson, DM Lawson, NP Burton, ...
Nature communications 12 (1), 150, 2021
422021
Discovery of nanomolar desmuramylpeptide agonists of the innate immune receptor nucleotide-binding oligomerization domain-containing protein 2 (NOD2) possessing …
M Gobec, T Tomašič, A Štimac, R Frkanec, J Trontelj, M Anderluh, ...
Journal of medicinal chemistry 61 (7), 2707-2724, 2018
412018
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20